Oren Knopfmacher

Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL.

NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA.

Carmenta Bioscience, Inc. provides biotechnology services. It offers technology that medical need in maternal and fetal health. The company was founded by Matthew Cooper, Atul J. Butte, and Bruce Ling in 2012 and is headquartered Palo Alto, CA.

Companion Medical, Inc. develops solutions for diabetes management called InPen. The company was founded by Sean Saint in 2013 and is headquartered in San Diego, CA.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

BD Biosciences, Systems & Reagents, Inc. provides tools and solutions to research and clinical laboratories in basic research, drug discovery, development, biopharmaceutical production and disease management. The company was founded on May 9, 1991 and is headquartered in San Jose, CA.

The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015.

Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.

Part of Becton, Dickinson & Co., Becton Dickinson Immunocytometry Systems manufactures medical instruments. The company is based in San Jose, CA.

The Preeclampsia Foundation is an organization that aims to address the significant unmet need for an effective treatment for preeclampsia, a common and severe complication of pregnancy characterized by high blood pressure and multiple organ failure. Preeclampsia affects between 3% and 5% of all pregnancies in the US and is responsible for approximately 20% of all preterm births. It can lead to a range of complications for both the mother and the baby, including multi-organ damage, seizures, and premature birth. Currently, delivery of the baby is the only definitive cure for preeclampsia. The signs and symptoms of preeclampsia can vary and include high blood pressure, acute kidney injury, swelling in the hands and face, severe headaches, vision changes, and abdominal pain. Treatment may include close monitoring of blood pressure and urine protein levels, bed rest, and medication to lower blood pressure.

Syapse, Inc. develops software solutions that enable healthcare providers to deploy precision medicine programs. Its medical platform is used to integrate complex genomic and clinical data to provide clinicians with actionable insights at point of care, enabling diagnosis, treatment, and outcomes tracking. The firm offers a suite of clinical applications built on the Syapse Precision Medicine Platform and designed to help healthcare providers implement and scale precision medicine at the point of care. The company was founded by Tony Loeser, Glenn S. Winokur, and Jonathan Hirsch in 2008 and is headquartered in San Francisco, CA.

Longwell & Associates is a law firm. The private company is based in Palo Alto, CA.

CorVista Health, Inc. develops medical imaging solutions. It offers Agilytics, a machine intelligence technology platform that analyzes phase space tomography data to identify and assess specific disease. The company is headquartered in Toronto, Canada.

CalCanada Biomed Fund LLC engages in investment activities. The company was founded in 2006 and is headquartered in Mountain View, CA.

MOCACARE Corp. develops and manufactures heart health monitoring devices. Its products include mocaheart and mocacuff. The company was founded by Daniel Wei-Chen Hong and Naama stauber in 2013 and is headquartered in Palo Alto, CA.

ABK Biomedical, Inc. develops embolotherapeutic products for the treatment of uterine fibroids. It engages in the development, production and sale of embolic agents and peripheral vascular delivery devices. The company was founded by Bob Abraham, Daniel Boyd and Sharon Kehoe in 2012 and is headquartered in Halifax, Canada.

Palmera Medical, Inc. provides technology support services. The company is headquartered in Mountain View, CA.

Better Health Technologies Inc is a modern medical supplier that focuses on delivering diabetes, incontinence, urology, ostomy, and wound care supplies. The company is based in San Francisco, CA. The company offers a wide range of products from all the leading brands, including CGMs, catheters, ostomy bags, and more. Better Health Technologies was founded by Adam Breckler and Naama Stauber Breckler, and Naama Stauber Breckler has been the CEO since incorporation.

Alembic LLC is a privately held American medical device incubator company founded in 2012 by Dr. Aaron Berez. The company focuses on bringing novel neurovascular solutions to market. Its first portfolio company, Cathera, Inc, developed the Phenom family of microcatheters optimized for intracranial navigation. The company has a strong manufacturing foundation focused on continuous quality improvement, and its products are shipped worldwide and used in interventional lifesaving procedures around the world. Alembic brings novel neurovascular solutions to market.

Enumera Molecular, Inc. is a life science tools company based in Ann Arbor, MI. The company has developed a scalable biomolecule assessment platform that enables lower cost and rapid clinical liquid biopsy tests. The company was founded in 2022 by Matthew Cooper with the mission of transforming the field of clinical molecular testing to a simpler, more actionable tool for physicians to benefit patient care.